US 11655282
Chimeric engulfment receptor molecules
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11655282 (Chimeric engulfment receptor molecules) held by Cero Therapeutics Holdings, Inc. expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cero Therapeutics Holdings, Inc.
- Grant date
- Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/5156, A61K2239/38